Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker (ACE/ARB) Surveillance
NCLEX-RN glossary · Pharmacological And Parenteral Therapies
Definition
The continuous monitoring for adverse effects in clients receiving angiotensin-converting enzyme inhibitors or ARBs, focusing on renal perfusion and electrolyte stability.
Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker (ACE/ARB) Surveillance in plain English
Priority identifies angioedema (airway threat) and hyperkalemia (cardiac threat) as non-negotiable reasons for medication stopping. The tempting mistake is attributing a dry, persistent cough to a common cold rather than recognizing it as a 'Red Flag' for ACE-inhibitor-induced bradykinin accumulation.
Also called: ACE inhibitor or ARB surveillance
Sign up free: all 276 NCLEX-RN terms as flashcards, plus practice questions with full explanations →
Related NCLEX-RN terms
- Acute kidney injury
- Acute transfusion reaction
- Adverse reaction after first dose
- Allergy versus side effect
- Antidepressant and mood-stabilizer surveillance
- Antimicrobial stewardship and toxicity
- Antipsychotic emergencies
- Antiseizure medication
- Beta blocker or rate-control toxicity
- Cardiovascular, Renal, and Anticoagulant Pharmacology
NCLEX-RN practice questions · NCLEX-RN flashcards · NCLEX-RN study guide